These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Public access versus proprietary rights in genomic information: what is the proper role of intellectual property rights? Mueller JM J Health Care Law Policy; 2003; 6(2):222-40. PubMed ID: 15017961 [No Abstract] [Full Text] [Related]
3. Intellectual property. Enhanced: intellectual property landscape of the human genome. Jensen K; Murray F Science; 2005 Oct; 310(5746):239-40. PubMed ID: 16224006 [TBL] [Abstract][Full Text] [Related]
4. [Genomic project network and the patents (discussion)]. Hayashizaki Y; Oinuma T; Kohtsuki S Tanpakushitsu Kakusan Koso; 2004 Dec; 49(17 Suppl):3001-16. PubMed ID: 15669291 [No Abstract] [Full Text] [Related]
5. Science and the law. Working through the patent problem. Walsh JP; Cohen WM; Arora A Science; 2003 Feb; 299(5609):1021. PubMed ID: 12586928 [No Abstract] [Full Text] [Related]
6. Intellectual property rights. Public sector collaboration for agricultural IP management. Atkinson RC; Beachy RN; Conway G; Cordova FA; Fox MA; Holbrook KA; Klessig DF; McCormick RL; McPherson PM; Rawlings HR; Rapson R; Vanderhoef LN; Wiley JD; Young CE Science; 2003 Jul; 301(5630):174-5. PubMed ID: 12855794 [No Abstract] [Full Text] [Related]
7. So many choices, so little money. Pennisi E Science; 2001 Oct; 294(5540):82-5. PubMed ID: 11588245 [No Abstract] [Full Text] [Related]
10. When the human genome project and state street collide. Locke SD; Kalow DA Nat Biotechnol; 2000 Sep; 18(9):1009-10. PubMed ID: 10973226 [No Abstract] [Full Text] [Related]
11. How can you patent genes? Eisenberg RS Am J Bioeth; 2002; 2(3):3-11. PubMed ID: 12230840 [TBL] [Abstract][Full Text] [Related]
12. The Human Genome Project: lessons from large-scale biology. Collins FS; Morgan M; Patrinos A Science; 2003 Apr; 300(5617):286-90. PubMed ID: 12690187 [No Abstract] [Full Text] [Related]
13. Genomic capital: public cultures and market logics of corporate biotechnology. Rajan KS Sci Cult (Lond); 2003 Mar; 12(1):87-121. PubMed ID: 15971369 [No Abstract] [Full Text] [Related]
15. Literature and patent analysis of the cloning and identification of human functional genes in China. Xia Y; Tang L; Yao L; Wan B; Yang X; Yu L Sci China Life Sci; 2012 Mar; 55(3):268-82. PubMed ID: 22527523 [TBL] [Abstract][Full Text] [Related]
17. Innovations and intellectual property: the case of genomic patenting. Jackson BA J Policy Anal Manage; 2003; 22(1):5-25. PubMed ID: 12722760 [TBL] [Abstract][Full Text] [Related]
18. Patent prosecution strategies for biotechnological inventions. Yeh JJ; Fernandez D Assay Drug Dev Technol; 2004 Dec; 2(6):697-702. PubMed ID: 15674028 [TBL] [Abstract][Full Text] [Related]
20. The Human Genome Project in the United States: a perspective on the commercial, ethical, legislative and health care issues. Mackler BF; Barach M J Int Bioethique; 1991; 2(3):149-57. PubMed ID: 11654898 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]